Tea and cancer chemoprevention: A comprehensive review

Asian Pacific Journal of Cancer Prevention

Volumn 8, Issue 2, 2007, Pages 155-166

  Shukla, Yogeshwer ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Animal models; Cancer prevention; Clinical trials; Epidemiological studies; Tea

Indexed keywords

ANTINEOPLASTIC AGENT; FLAVONOID; PHENOL DERIVATIVE; POLYPHENOLS; UNCLASSIFIED DRUG;

CELL DIVISION; DIET; FEMALE; HUMAN; MALE; NEOPLASM; PATHOLOGY; REVIEW; TEA;

ANTICARCINOGENIC AGENTS; CELL DIVISION; DIET; FEMALE; FLAVONOIDS; HUMANS; MALE; NEOPLASMS; PHENOLS; TEA;

EID: 39649100905     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Agarwal R, Mukhtar H, (1991). Cutaneous chemical carcinogenesis, in Pharmacology of Skin. Ed., CRC Press, Boca Raton, FL, pp 371-87.
2. Apostolides Z, Balentine DA, Harbowy ME, et al, (1997). Inhibition of PhIP mutagenicity by catechins, and by theaflavins and gallate esters. Mutat Res, 389, 167-72.
3. Armstrong B, Garrod A, Doll RA, (1976). Retrospective study of renal cancer with special reference to coffee and animal protein consumption. Br J Cancer, 33, 127- 36.
4. Balentine DA, Wiseman SA, (1997). The chemistry of flavonoids. Crit Rev Food Sci Nutr, 37, 693-704.
5. Bianchi GD, Cerhan JR, Parker AS, et al, (1994). Selective induction of rat hepatic CYP1 and CYP4 proteins and of peroxisomal proliferation of green tea. Carcinogenesis, 15, 2575-9.
6. Chatterjee ML, Agarwal R, Mukhtar H, (1996).Ultraviolet B radiation-induced DNA lesions in mouse epidermis: an assessment using a novel 32P-postlabelling technique. Biochem Biophys Res Commun, 229, 590-5.
7. Chen D, Daniel KG, Kuhn DJ, et al, (2004). Green tea and tea polyphenols in cancer prevention. Front Biosci, 9, 2618-31.
8. Chung FL, Wang M, Rivenson A, et al, (1998). Inhibition of lung carcinogenesis by black tea in Fischer rats treated with a tobacco-specific carcinogen: caffeine as an important constituent. Cancer Res, 51, 4096-101.
9. Claude J, Kunze E, frentzel-Beyme R, et al, (1986). Life-style and occupational risk factors in cancer of the lower urinary tract. Am J Epidemiol,124, 578-89.
10. D'Avanzo B, La Vecchia C, Franceschi S, et al, (1992). Coffee consumption and bladder cancer risk. Eur J Cancer, 28, 1480-4.
11. Dales LG, Friedman GD, Ury HK, et al, (1979). A case-control study of relationship of diet and other traits to colorectal cancer in American blacks. Am J Epidemiol, 109, 132-44.
12. Elmets CA, (1991). Cutaneous photocarcinogenesis, in Pharmacology of the Skin, Mukhtar H, Ed., CRC Press, Boca Raton, FL, pp 389-416.
13. Embola CW, Sohn OS, Fiala ES, et al, (2002). Induction of UDPglucuronosyltransferase 1 (UDP-GT1) gene complex by green tea in male F344 rats. Food Chem Toxicol, 40, 841-4.
14. Frei B, Higdon JV, (2003). Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr, 133, 3275-84.
15. Fujiki H, (1999). Two stages of Oncol. cancer prevention with green tea. J Cancer Res Clin, 125, 589-97.
16. Gao CM, Takezaki T, Wu JZ, et al, (2002). Glutathione-Stransferases M1 (GSTM1) and GSTT1 genotype, smoking, consumption of alcohol and tea and risk of esophageal and stomach cancers: a case-control study of a high-incidence area in Jiangsu Province,China. Cancer Lett, 188, 95-102.
17. Gao YT, McLaughlin JK, Blot WJ, et al, (1994). Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst, 86, 855-8.
18. Gensler HL, Timmermann BN, Valcic S, et al, (1996). Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green tea. Nutr Cancer, 26, 325-35.
19. Goldbohm RA, Hertog MG, Brants HA, et al, (1996). Consumption of black tea and cancer risk: a prospective cohort study. J Natl Cancer Inst, 88, 93-100.
20. Goodman MT, Morgenstern H, Wynder EL, (1986). A casecontrol study of factors affecting the development of renal cell cancer. Am J Epidemiol, 124, 926-41.
21. Graham HN, (1992). Green tea, composition, consumption and polyphenols chemistry. Prev Med, 21, 334-50.
22. Hara Y, Matsuzaki S, Nakamura K, (1989). Antiumor activity of green tea catechin. J Jpn Soc Nutr Food Sci (in Japanese) 42, 39-45.
23. Harbowy ME, Balentine DA, (1997). Tea chemistry. Critical Rev Plan Sci,16, 415-80.
24. Harnack LJ, Anderson KE, Zheng W, et al, (1997). Smoking, alcohol, coffee, and tea intake and incidence of cancer of the exocrine pancreas: the Iowa Womens Health Study. Cancer Epidemiol Biomarkers Prev, 6, 1081-6.
25. Heilbrun LK, Nomura A, Stemmermann GN, (1986). Black tea consumption and cancer risk: a prospective study. Br J Cncer, 54, 677-83.
26. Henderson BE, Louie E, Soo Hoo Jing J, et al, (1976). Risk factors associated with nasopharyngeal carcinoma. New Eng J Med, 295, 1101-6.
27. Hernaez J, Xu M, Dashwood R, (1998). Antimutagenic activity of tea towards 2-hydroxyamino-3-methylimidazo (4,5) quinoline: effect of tea concentration and brew time on electrophillic scavenging. Mutat Res, 402, 299-306.
28. Huang MT, Ho CT, Wang ZY, et al, (1992). Inhibitory effects of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis, 13,947- 54.
29. Huang MT, Xie JG, Wang ZY, et al, (1997) Effects of tea, decaffeinated tea, and caffeine on UVB light-induced complete carcinogenesis in SKH-1 mice: demonstration of caffeine as a biologically important constituent of tea. Cancer Res, 57, 2623-9.
30. Ichikawa D, Matsui A, Imai M, et al, (2004). Effect of Various Catechins on the IL-12p40 Production by Murine Peritoneal Macrophages and a Macrophage Cell Line, J774.1. Biol Pharm Bull, 9, 1353-8.
31. Inoue M, Tajima K, (1998) Tea and coffee consumption and risk of digestive tract cancers: data from comparative casereferent study in Japan. Cancer Causes Control,9, 209-16.
32. Jain MG, Hislop GT, Howe GR, et al, (1998). Alcohol and other beverage use and prostate cancer risk among Canadian men. Int J Cancer,78, 707-11.
33. Jatoi A, Ellison N, Burch AP, et al, (2003). A phase II trail of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer, 97, 1441-6.
34. Jiang MC, Yang-Yen HF, Yen JJY, et al, (1996). Curcumin induces apotosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer, 26, 111-20.
35. Katiyar SK, (2003). Skin photoprotection by green tea: antioxidant and immunomodulatory effects. Curr Drug Targets Immune Endocr Metabol Disord, 3, 234-42.
36. Katiyar SK, Agarwal R, Mukhtar H, (1993). Protective effects of against N-nitrosodiethylamine and benzo(a)pyreneinduces forestomach and lung tumorigenesis in A/J mice by green tea. Carcinogenesis,14, 849-55.
37. Katiyar SK, Agarwal R, Mukhtatr H, (1992a). Green tea in chemoprevention of cancer. Comprehensive Therapy, 18, 3-8.
38. Katiyar SK, Agarwal R, Wang ZY, et al, (1992b). Epigallocatechin-3-gallate in Camellia sinensis leaves from Himalayan region of Sikkim: inhibitory effects against biochemical events and tumor initiation in SENCAR mouse skin. Nutr Cancer, 18, 73-83.
39. Katiyar SK, Agarwal R, Wood GS, et al, (1992c). Inhibition of 12-O-tetradecanoylphorbol-13-acetate-caused tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated SENCAR mouse skin by a polyphenolic fraction isolated from green tea. Cancer Res, 52, 6890-7.
40. Katiyar SK, Mukhtar H, (1996). Tea in chemoprevention of cancer: epidemiologic and experimental studies (review). Int J Oncol, 8, 221-38.
41. Katiyar SK, Mukhtar H, (1997) Tea antioxidants in cancer chemoprevention. J Cell Biochem Suppl, 27, 59-67.
42. Lee MJ, Lambert MJ, Yang CS. (2004). Delivery of tea polyphenols to the oral cavity by green tea leaves and black tea extract. Cancer Epidemiol Biomarkers Prev, 3,132-7.
43. Lee MJ, Wang ZY, Li H, (1995). Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemol Biomarkers Prev, 4, 393-9.
44. Li ZG, Shimada Y, Sato F, et al, (2003). Promotory effects of hot water on N-nitromethylbenzylamine-induced esophageal tumorigenesis in F344 rats. Oncol Rep, 10, 421- 6.
45. Lin TM, Chen KP, Lin CC, et al, (1973). Retrospective study on nasopharyengeal carcinomas. J Natl Cancer Inst, 51, 1403-8.
46. Lu YP, Lou YR, Xie JG, et al, (1997) Inhibitory effect of black tea on the growth of established skin tumors in mice: effects on tumor size, apoptosis, mitosis and bromodeoxyuridine incorporation into DNA.Carcinogenesis, 18, 2163-9.
47. McLaughlin JK, Mandel JS, Blot WJ, (1984). A population-based case-control study of renal cell carcinoma. J Natl Cancer Inst,72, 275-84.
48. Miller AB, Howe GR, Jain M, et al, (1983). Food items and food groups as risk factors in a case-control study of diet and colo-rectal cancer. Int J Cancer, 32, 155- 66.
49. Mittal A, Pate MS, Wylie RC, et al, (2004). EGCG downregulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int J Oncol, 24, 703-10.
50. Morgan RW, Jain MG, (1974). Bladder cancer: smoking, beverages and artificial sweeteners. Can Medical Assoc J, 111, 1067-70.
51. Mukhtar H, Katiyar SK, Agarwal R, (1994). Green tea and skin: anticarcinogenic effects. J Investigative Dermatol, 102, 3-7.
52. Nakachi K, Suemasu K, Higashi Y, et al, (1998). Influence of drinking tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res, 89, 254-61.
53. Nomura AM, Kolonel LN, Hankin JH et al, (1991). Dietary factors in cancer of the lower urinary tract. Int J Cancer, 48, 199-205.
54. Orner GA, Dashwood WM, Blum CA, et al, (2002). Response of Apc(min) and A33 (delta N beta-cat) mutant mice to treatment with tea, sulindac, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine(PhIP).Mutat Res, 30, 506-7.
55. Phillips RL, Snowdon DA, (1985). Dietary relationship with fatal colorectal cancer among Seventh-Day Adventists. J Natl Cancer Inst, 74, 307-37.
56. Pillai SP, Mitscher LA, Menon SR, et al, (1999). Antimutagenic/ antioxidant activity of green tea components and related compounds. J Environ Pathol Toxicol Oncol, 18,147-58.
57. Pisters KM, Newman RA, Coldman B, et al, (2001) Phase I trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol, 19, 1830-8.
58. Rice-Evans CA, Miller NJ, Bolwell PG, et al, (1995). The relative antioxidant activities of plant derived polyphenolic flavonoids. Free Radical Res, 22, 375- 88.
59. Santana-Rios G, Orner GA, Amantana A, et al, (2001). Potent antimutagenic activity of white tea in comparison with green tea in the Salmonella assay. Mutat Res, 495, 61-74.
60. Schut HA, Yao R, (2000). Tea as a potential chemopreventive agent in PhIP carcinogenesis: effects of green tea and black tea on PhIP-DNA adduct formation in female F-344 rats. Nutr Cancer, 36,52- 8.
61. Setiawan VW, Zhang ZF, Yu GP, et al, (2001). Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int J Cancer, 92, 600- 4.
62. Shanmugaratnam K, Tye CY, Goh EH, et al, (1978). Etiological factors on naso-pharyngeal carcinoma: a hospital-based, retrospective, case control, questionnaire study, in Nasopharyngeal Carcinoma, Etiology and Control, Ito, Y. Ed.,IARC, Lyon, pp 199-212.
63. Shiraki M, Hara Y, Osawa T, et al, (1994). Antioxidative and antimutagenic effects of theaflavins from black tea. Mutat Res, 323, 29-34.
64. Shukla Y, Javed S, (2000). Effect of black tea extract on transplantable and solid tumors in Swiss albino mice. Biomed Env Sci, 10, 213- 8.
65. Shukla Y, Taneja P, (2002). Antimutagenic effects of black tea on pulmonary tumors in Swiss albino mice. Cancer Lett,176, 137- 41.
66. Shukla Y, Arora A, Taneja P, (2003). Antigenotoxic potential of certain dietary constituents. Terato Carcino Mutagen, 1, 323-35.
67. Siddiqui IA, Afaq F, Adhami VM, et al, (2004). Antioxidants of the beverage tea in promotion of human health. Antioxid Redox Signal, 6, 571-82.
68. Simon D, Yen S, Cole P, (1975).Coffee drinking and cancer of the lower urinary tract. J Natl Cancer Inst, 54, 587-91
69. Sugiyama T, Sadzuka Y, (2004). Theanine, a specific glutamate derivative in green tea, reduces the adverse reactions of doxorubicin by changing the glutathione level. Cancer Lett, 212,177-84.
70. Taneja P, Arora A, Shukla Y, (2003). Antimutagenic effects of black tea in the Salmonella typhimurium reverse mutation assay. Asian Pac J Cancer Prev, 4, 193- 8.
71. (2000) Tea Consumption and risk of bladder and kidney cancers in a population-based case-control study. Am J Epidemiol, 151, 377-83.
72. Wang LD, Zhou Q, Feng CW et al,, (2002). Intervention and follow up on human esophageal precancerous lesions in Henan, Northern China, a high incidence area for esophageal cancer. Gan To Kagaku Ryoho, 29, 159-72.
73. Wang ZY, Agarwal R, Khan WA, et al, (1992a) Protection against benzo(a)pyrene and N-nitrsodimethylamine-induced lung and forestomach tumorigenesis in A/J mice by water extracts of green tea and licorice. Carcinogenesis, 13, 1491- 4.
74. Wang ZY, Das M, Bickers DR, et al, (1988). Interaction of epicatechins derived from green tea with rat hepatic cytochrome P-450. Drug Metab Dispo, 16, 98-103.
75. Wang ZY, Huang MT, Ferraro T, et al, (1992b). Inhibitory effect of green tea in drinking water in tumorigenesis by ultraviolet light and 12-O-tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice. Cancer Res, 52, 1162- 71.
76. Wang ZY, Huang MT, Lou YR, et al, (1994). Inhibitory effect of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz(a)anthracene-initiated SKH-1 mice. Cancer Res, 54, 3428- 35.
77. Wang ZY, Jhan WA, Bickers DR, et al, (1989). Protection against polycyclic hydrocarbon induced skin tumor initiation in mice by green tea polyphenols. Carcinogenesis, 10, 411- 5.
78. Wang ZY, Wang LD, (1995) Inhibition of N-nitrosomethyl benzylamine induced esophageal tumorigenesis in rat by green and black tea. Carcinogenesis, 16, 2143-8.
79. Weisburger JH, (1997). Tea and health a historical prespective. Cancer Lett, 114, 315- 7.
80. Wenzel U, Herzog A, Kuntz S, et al, (2004). Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics, 4, 2160-74.
81. Yang CS, Maliakal P, Meng X, (2002). Inhibition of carcinogenesis by tea. Ann Rev Pharmacol Toxicol, 42, 25-54.
82. Yang YS, Wang QD, Zhou YZ, (1992). Effects of Chinese green tea on the immune function of mice bearing tumor and their antitumor activity. Chung Hua Liu Hsing Ping Hsueh tsa Chih. Chinese J Cancer Res, 26, 5-7.
83. Yi ZX, Yi CS, Li ZY, (1984). Effects of green tea on transplanted tumors. Tumor, 4,128-34 (in Chinese).
84. Yoo HG, Shin BA, Park JC, et al, (2002).Induction of apoptosis by the green tea flavonol (-)-epigallocatechin-3-gallate in human endothelial ECV 304 cells. Anticancer Res, 22, 3373-8.
85. Yoshizawa S, (1996). (-)Epigallactocatechin gallate, the main constituent of Japanese green tea, inhibits tumor promotion of okadaic acid. Fukuoka Igaku Zasshi, 87, 215-21.
86. Yoshizawa S, Horiuchi T, Fujiki H, et al, (1987). Antitumor promoting activity of (-)epigallactocatechin gallate, the main constituent of tannin in green tea. Phytother Res, 1, 44-7.
87. Yu MC, Mack TM, Hanisch R, et al, (1986). Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factor for renal cell carcinoma. J Natl Cancer Inst, 77, 351- 6.
88. Zheng W, Doyle TJ, Kushi LH, et al, (1996). Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol, 144, 175-82.
89. Zheng Y, Song HJ, Kim CH, et al, (2004). Inhibitory effect of epigallocatechin 3-O-gallate on vascular smooth muscle cell hypertrophy induced by angiotensin II. J Cardiovasc Pharmacol, 43, 200- 8.